Brandon Meier, DMD
Oral and Maxillofacial Surgery · Waltham, MANPI 1326214248
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,354 of the $2,932 with a category attached, or 80.3%. 4 manufacturers reported payments, led by Zimvie Inc. at 52.2% of the total.
Across 76 payments — averaging $38.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimvie Inc.$2K
- Zimmer Biomet$707
- Keystone Dental Inc.$425
- Southern Implants North America Inc$269
What the payments were for
- Food & beverage$2,35480%
- Education$2007%
- Entertainment$37813%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimvie Inc. | 51 | $1,531 |
| Zimmer Biomet | 15 | $707 |
| Keystone Dental Inc. | 4 | $425 |
| Southern Implants North America Inc | 6 | $269 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Diem2$200
How this compares
$2,932 in reported general payments places this provider in the 80th percentile of 247 oral and maxillofacial surgery providers in Massachusetts.
See all oral and maxillofacial surgery providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluocinonide | 39 | $1,287 |
| Amoxicillin | 214 | $691 |
| Chlorhexidine Gluconate | 179 | $675 |
| Clindamycin Hcl | 49 | $293 |
| Penicillin V Potassium | 58 | $202 |
| Oxycodone Hcl | 28 | $65 |
Paid to pharmacies, not to this prescriber.
Other oral and maxillofacial surgery in Waltham
- Jonathan BishopWaltham$2K
- William BontempiWestfield$93K
- Briana BurrisBoston$67K
- Cory ResnickBoston$65K
- David LustbaderQuincy$54K
- Daniel ChoiBoston$48K
- David ChangBoston$42K
- Miguel VidalBoston$25K
- Jose MarchenaPeabody$24K
- Timothy OsbornMedford$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.